Resources

Everything you need to evaluate the science.

TissueTinker Technical Whitepaper

The full technical story: how the TTB-Series bioinks are built, and what tissue specificity changes in practice. Invasion fidelity, human-like drug response, and stroma that behaves like real tissue. Free to read, no form.

Download the whitepaper (PDF)

Selected Literature

The research TissueTinker is built on. Our technology grew directly out of peer-reviewed work at McGill, and we’ve been expanding it ever since.

Mascort, J. K. (2023). Development and Characterization of a Co-culture Model of Head and Neck Cancer Using Bioprintable Decellularized Extracellular Matrix Bioinks. McGill University (Canada).

The foundational work TissueTinker originated from and has since expanded.
ECM stiffness as a driver of tumor mechanotransduction and cancer cell behavior.

Backs the System-page stiffness claims and the stiffness chart.
New approach methodologies (NAMs) and the FDA/EMA shift past animal-only testing.

See the FDA announcement and NIH policy shift.